| 000 | 01779nam a2200409 a 4500 | ||
|---|---|---|---|
| 001 | EBC3020832 | ||
| 003 | MiAaPQ | ||
| 005 | 20240121041722.0 | ||
| 006 | m o d | | ||
| 007 | cr cn||||||||| | ||
| 008 | 100617s2010 nyu sb 001 0 eng d | ||
| 010 | _z 2010025918 | ||
| 020 | _z9781617288517 (softcover) | ||
| 020 | _a9781617610332 (electronic bk.) | ||
| 035 | _a(MiAaPQ)EBC3020832 | ||
| 035 | _a(Au-PeEL)EBL3020832 | ||
| 035 | _a(CaPaEBR)ebr10680970 | ||
| 035 | _a(OCoLC)923664535 | ||
| 040 |
_aMiAaPQ _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 |
_aRC848.H425 _bF34 2010 |
|
| 082 | 0 | 4 |
_a616.3/623 _222 |
| 100 | 1 | _aFahim, Magid A. | |
| 245 | 1 | 0 |
_aHepatitis C infection in dialysis _h[electronic resource] / _cMagid A. Fahim and David W. Johnson. |
| 260 |
_aNew York : _bNova Biomedical Books/Novinka, _cc2010. |
||
| 300 | _a46 p. | ||
| 490 | 1 | _aNephrology research and clinical developments | |
| 504 | _aIncludes bibliographical references (p. [35]-41) and index. | ||
| 505 | 0 | _aEpidemiology -- Risk factors for HCV acquisition in haemodialysis patients -- Prevention of HCV transmission in haemodialysis units -- Diagnosis, screening, and evaluation -- Hepatic pathology and complications -- Treatment and monitoring -- Outcomes. | |
| 533 | _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
| 650 | 0 | _aHepatitis C. | |
| 650 | 0 |
_aHemodialysis _xComplications. |
|
| 655 | 4 | _aElectronic books. | |
| 700 | 1 |
_aJohnson, David W. _q(David Wayne), _d1964- |
|
| 710 | 2 | _aProQuest (Firm) | |
| 830 | 0 | _aNephrology research and clinical developments series. | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3020832 _zClick to View |
| 999 |
_c154329 _d154329 |
||